Chemotherapy is a process that uses drugs for the control, cure, and palliation of cancer. Cancer, in its early stages, can be cured and controlled using chemotherapy. Also, chemotherapy is used to ease the symptoms caused by cancer in the later stages. Chemotherapy pumps or chemotherapy infusion pumps help in the administration of chemotherapy drugs in a controlled manner. The chemotherapy infusion pump is made up of a hard plastic bottle, and inside the plastic bottle, there is a balloon that holds the chemotherapy drug. The balloon pushes the chemo in the patient’s body, and the flow restrictor (outside the balloon) helps in restricting the flow of the chemo.
Cancer is one of the leading causes of death globally after cardiovascular diseases. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. An increase in the cancer-afflicted population is anticipated to be a key driver of the chemotherapy infusion pumps market. According to a Centers for Disease Control and Prevention (CDC) report in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. It is also expected that this number would reach 25.4 million by the end of 2024. Over 60% of the world’s new cancer cases occur in Asia, Africa, and South America. Nearly the same percentage of cancer deaths also take place in these regions. Stomach, liver, lung, breast, and esophageal cancer are most prevalent among populations worldwide.
The global chemotherapy infusion pumps market is primarily driven by an increase in the incidence and prevalence of cancer. In addition, increase in the adoption of chemotherapy infusion pumps for the delivery of chemo medicines, increase in the geriatric population, advancements in health care are expected to boost the growth of the global chemotherapy infusion pumps market in the next few years. Furthermore, existing market players are deploying advanced techniques and strategies to come up with novel ways for manufacturing technologically enhanced infusion pumps. This is likely to propel demand for infusion pumps for chemotherapy during the forecast period. However, frequent product recalls and stringent government regulations are expected to restrain the market in the coming years.
The global chemotherapy infusion pumps market can be segmented based on type, end-user, and region. Based on type, the market can be divided into large volume pump (LVP), elastomeric pump, and syringe pump. Based on end-user, the market can be divided into home care, hospitals, and clinics.
In terms of region, the global chemotherapy infusion pumps market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a dominant share of the market in 2017, due to the high rate of adoption of chemotherapy infusion pumps in the region. Also, a rise in prevalence of cancer and presence of a large number of manufacturers in North America are expected to boost the chemotherapy infusion pumps market during the forecast period. Asia Pacific and Latin America are expected to be highly lucrative regions of the chemotherapy infusion pumps market in the near future. The market in these regions is projected to expand rapidly during the forecast period, owing to a large population base, increase in the number of hospitals, and rise in the adoption of infusion pumps for chemotherapy.
Key players operating in the global chemotherapy infusion pumps market include ICU Medical, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Halyard Health, Inc., Baxter, Fresenius SE & Co. KGaA, Smiths Group plc., Moog Inc., ZynoMed, and Micrel Medical Devices SA.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.